We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CHINA POISED TO BECOME GLOBAL HUB FOR API PRODUCTION
CHINA POISED TO BECOME GLOBAL HUB FOR API PRODUCTION
April 6, 2004
The planned merger of Oriental Wave Holdings and Dragon Pharmaceutical could lead to the first Chinese firm being listed on Wall Street — evidence of China’s rise as a global player in the pharmaceutical industry, especially in the production of active pharmaceutical ingredients (APIs), analysts say.